AGORACOM Beyond The Expert Welcomes Venture Capitalist Leigh Hughes To Discuss Mountain Valley MD, Valeo Pharma and Xphyto Therapeutics

AGORACOM followers have given us great feedback on our hit series  "Beyond The Press Release" (BTPR) in which we speak with small cap CEO's  about important press releases in greater depth and, quite frankly, in  layman's terms for investors to truly understand their significance. Nowhere is this more important than in the world of disruptive  technologies, biotech and pharma.  Each of these industries share two  distinct traits: Whereas BTPR tells these stories from the side of small cap public  companies, Beyond The Expert (BTE) tells these stories from the  perspective of experts on these topics - and we couldn't think of anyone  better to start off this series than Leigh Hughes.The possibility for explosive growth with disruptive new products Difficulty in conveying disruptive new products that, by their nature, have never been seen before by investors. Leigh is a Venture Capitalist who I've personally watched conduct  incredible due diligence and invest into many small cap companies that  have generated incredible returns over 12-18 month periods. Leigh is so good at what he does that many global private equity  funds and institutions take his call and often follow him into  investments he chooses to make.  Moreover, he serves as an advisor to  several small cap companies. If you ever wanted to truly learn how to become a great small cap investor, it doesn't get much better than this. Without further adieu, watch this great interview with Leigh Hughes  and make sure to provide us with your feedback via comments on Twitter,  YouTube or wherever you may be watching or listening.